Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Advancing to IND-enabling studies with multiple drug candidates
The facility is among 12 centres established worldwide, and the first in Asia
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
The goal for the project is the identification and optimization of anti-viral compounds.
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
SPARC enters definitive agreement to monetise rare paediatric disease PRV, unlocking capital for R&D and strategic growth
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
Subscribe To Our Newsletter & Stay Updated
